MiraDx Creates COVID-19 Tests for Nursing Homes, Cops, Firefighters & Healthcare Workers
Tami Abdollah is dot.LA's senior technology reporter. She was previously a national security and cybersecurity reporter for The Associated Press in Washington, D.C. She's been a reporter for the AP in Los Angeles, the Los Angeles Times and for L.A.'s NPR affiliate KPCC. Abdollah spent nearly a year in Iraq as a U.S. government contractor. A native Angeleno, she's traveled the world on $5 a day, taught trad climbing safety classes and is an avid mountaineer. Follow her on Twitter.
When Dr. Joanne Weidhaas lost their family's orange Tabby cat named Pumpkin, to a "weird coronavirus" three years ago, the RNA biologist threw herself into a month-long study of it. She wanted to get to the bottom of what had happened.
So once this novel coronavirus pandemic hit, Weidhaas realized she was strangely well-equipped for research and testing.
"This (new coronavirus) comes along and, I mean, we've done all the research on it, and I sit down with the head of my lab (and) we just said 'we can actually really do that,'" Weidhaas said. "We have all the equipment, we have the expertise, we're a high-complexity molecular diagnostics lab, which is exactly poised to look at this."
Indeed, Weidhaas wears multiple hats as co-founder of L.A.-based MiraDx and a professor at the David Geffen School of Medicine at UCLA. Her company actually started 10 years ago after she and her co-founder discovered a new group of RNA biomarkers that MiraDx then used to help determine cancer risk as well as the response to cancer treatment.
Now she's focused on ways to help detect and hopefully stop the spread of the novel coronavirus that has already caused 78 deaths and 4,000 cases in Los Angeles County. So far, MiraDx has been in discussion with several nursing homes to provide tests for their staff and talking with L.A. County about providing tests. The company is geared up to begin running as many as 4,000 tests a day starting Monday and is hoping to run more than 9,000 tests by the end of April.
The company is planning to add staff so that it can run tests 24/7. MiraDx has already processed its first five positive and first five negative results that it planned to submit, per protocol for cleared labs, to the FDA on Friday.
MiraDX is one of a slew of companies that have repurposed their existing businesses to address the lack of resources that local governments and front-line healthcare workers have been facing. It's also one example of L.A.'s relatively recent move into the world of biotech, an area of business that is usually more closely associated with San Diego.
It was the day after Weidhaas' birthday, 2 ½ weeks ago, as the coronavirus was really starting to overtake headlines, that she suddenly realized the company could and should do this with their lab.
Dr. Joanne Weidhaas wears multiple hats as co-founder of L.A.-based MiraDx and a professor at the David Geffen School of Medicine at UCLA. Courtesy of MiraDx
It's been a sleep-deprived, whirlwind ever since. The company has since transitioned its CLIA-certified lab to provide COVID-19 tests for essential works, prioritizing hospital and field-based healthcare workers who provide direct patient care and also first responders.
The company will distribute the tests — which cost $150, — for free to those frontline workers and organizations through (tax deductible) donations from its nonprofit sister organization, MiraKind. So far, the company has raised $75,000 in just a few days.
In order to prioritize essential workers and ensure their test results are processed quickly, Weidhaas said the company is not currently doing any direct-to-consumer testing. The lab should be able to process results within 48 hours, but is hoping to eventually cut that down to as little as four hours, she said. Those results are sent directly to the doctor and also the patient on their website at the same time.
The test uses an oropharynx, or back-of-the-mouth-area, swab. The PCR machine that analyzes the RNA, which is pulled from a patient's sample, is "very sensitive" and is set up to amplify a small an amount of the virus to come up positive, Weidhaas said.
The technique has more than 90% accuracy, she noted, and is the best method for identifying whether someone is sick at the time with COVID-19.
"We just need to help people and this is so right in our mission to do that. It's just this huge, incredible humanitarian need, even though it's kind of a turn in a direction," Weidhaas said.
PCR tests such as MiraKind's are more effective for testing when a person is infected early on. That's because the first antibodies — indicators that your body has fought infection — don't usually appear until seven to 10 days after infection, said Dr. Jeffrey Klausner, a University of California, Los Angeles epidemiologist who is also a Professor of Medicine in the Division of Infectious Diseases and the Program in Global Health.
Weidhaas hopes that the people who participate, like for their breast cancer tests, opt in to provide ongoing online updates about their status so that ultimately more research studies can be done. She also hopes to add data to a heat map to help state and local officials determine where there are high-loads of cases.
While more testing is helpful, Klausner said the big issue right now is that the FDA has been slow to approve home collection of samples that would allow people to mail in their samples like 23andMe and other direct-to-consumer genomic testing kits out there.
"Could you imagine that people could get a home collection box from Amazon.com or other internet (shopping) providers, never leave their house, collect a specimen, drop it in the mail, and two days later get a test result," Klausner said.
Do you have a story that needs to be told? My DMs are open on Twitter @latams. You can also email me at tami(at)dot.la, or ask for my Signal.
- medtech - dot.LA ›
- biotech-in-l.a. - dot.LA ›
- The COVID-19 Crisis is Creating a New Biotech Culture in L.A. - dot.LA ›
- Guest Column: Here's How Businesses Can Make Sure their Employees Are Virus-Free - dot.LA ›
- Join Us For Our Next Virtual Pitch Showcase on Healthcare - dot.LA ›
- Watch Three Los Angeles Health Startups Pitch Investors - dot.LA ›
- Can LA County's New Fund Get Local Biotech Startups to Stick Around? - dot.LA ›
- Quantgene Aims to Detect Cancers Far Earlier Using Data - dot.LA ›
Subscribe to our newsletter to catch every headline.
dot.LA hosted its first virtual pitch showcase on Thursday featuring three emerging companies that will have a positive impact on the current COVID-19 crisis. Founding entrepreneurs from Flowly, Shared Harvest Fund, and Meal Share talked through their business plans, shared decks, and explained their market strategy,
Anna Barber is an Investor, advisor, connector and coach for founders at Techstars LA and The Fund LA.
Spencer Rascoff is the cofounder of dot.LA
- Startups - dot.LA ›
- Join Us For dot.LA's Startup Pitch Showcase - dot.LA ›
- Los Angeles' Tech and Startup Scene is Growing. - dot.LA ›
- los-angeles-startups - dot.LA ›
- Top 50 Hottest Los Angeles Startups ›
Join us at 11:00 a.m. PST August 4th for the next dot.LA Strategy Session on "The Future of Sports."
The Rams and Chargers are set to play in a brand new $5.5 billion stadium in Inglewood this season that is being billed as the most technologically advanced in the world. Meanwhile, Dodger Stadium just completed a $100 million update and L.A. will be getting a new pro women's soccer team, Angel City, in 2022 backed by high profile VC's and celebrities.
Julie Uhrman, Founder and President at WFC LA (Angel City)
Julie Uhrman, Founder and President at WFC LA (Angel City)<p>Founder and president of Angel City, the consortium who received the rights from the NWSL to officially bring a women's soccer team to Los Angeles in 2022. </p><p>Uhrman was named head of media at Playboy in 2018 after serving as Lionsgate's GM of over-the-top ventures, overseeing the company's Tribeca Shortlist, Comic-Con HQ, Laugh Out Loud in partnership with Kevin Hart and Pantaya. </p><p>Prior to joining Lionsgate, Uhrman worked at VR vendor Jaunt as head of platform business development. She was the founder and CEO of OUYA, an Android-based game console for living room, which raised $8.6 million through Kickstarter and then went on to secure venture funding from Kleiner Perkins and Alibaba before the company was acquired by Razer in 2015. Previously Uhrman held executive roles in digital and game companies including IGN Entertainment and Vivendi Universal.</p>
Kevin Demoff, Chief Operating Officer at Los Angeles Rams
Kevin Demoff, Chief Operating Officer at Los Angeles Rams<p>Kevin Demoff is in his 11th year as chief operating officer with the Rams. In this capacity, Demoff serves as the team's top front office executive and liaison to owner and chairman, Stan Kroenke, on all organizational matters.</p><p>Demoff was recognized by the Sports Business Journal as one of its "Forty under 40" class members of 2016 and in 2010 he was named one of the "NFL's 10 Future Power Brokers" by Sports Illustrated.</p><p>Prior to joining the Rams, Demoff spent the previous four seasons (2005-08) with the Tampa Bay Buccaneers, where he served as a consultant before being named senior assistant in 2006. In this capacity, Demoff assisted General Manager Bruce Allen in contract negotiations, salary cap management, strategic planning and both college and pro scouting. During his tenure with the Buccaneers, the team captured NFC South titles in 2005 and 2007 while posting a winning record in three of his four seasons.</p>
Ben Bergman, Senior Reporter at dot.LA
Ben Bergman, Senior Reporter at dot.LA<p>Ben Bergman is the newsroom's senior reporter, covering venture capital. Previously he was a senior reporter/host at KPCC, a producer at Gimlet Media and NPR and produced two investigative documentaries for KCET. He has been a frequent on-air contributor to NPR and Marketplace and has written for The New York Times. Bergman was a 2017-2018 Knight-Bagehot Fellow in Economic and Business Journalism at Columbia Business School. He enjoys skiing, playing poker, and cheering on The Seattle Seahawks.</p>
- Kobe Bryant Remembered as Venture Capitalist in L.A. - dot.LA ›
- More Sports Video App Aims to Bring NBA to China - dot.LA ›